Loading…
Incidence and risk factor for infection of totally implantable venous access port
Background Totally implantable venous access ports (TIVAP) have been widely used in cancer patients for many years. The early infection (within 30 days after TIVAP implantation) rate of TIVAP accounts for about one-third of all TIVAP infections, and early infection often causes port removal and affe...
Saved in:
| Published in: | Langenbeck's archives of surgery 2022-02, Vol.407 (1), p.343-351 |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c347t-b0bac013da4ee5af5a4f51b860e4f0755e4f33abcd4d8d81bd0c97622414f11e3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c347t-b0bac013da4ee5af5a4f51b860e4f0755e4f33abcd4d8d81bd0c97622414f11e3 |
| container_end_page | 351 |
| container_issue | 1 |
| container_start_page | 343 |
| container_title | Langenbeck's archives of surgery |
| container_volume | 407 |
| creator | Chang, Tung-Cheng Yen, Min-Hsuan Kiu, Kee-Thai |
| description | Background
Totally implantable venous access ports (TIVAP) have been widely used in cancer patients for many years. The early infection (within 30 days after TIVAP implantation) rate of TIVAP accounts for about one-third of all TIVAP infections, and early infection often causes port removal and affects subsequent cancer treatment. This study investigated the incidence and risk factors for early and late infection after TIVAP implantation.
Methods
From January 2013 to December 2018, all adult cancer patients who received TIVAP implantation in Taipei Medical University Shuang-Ho Hospital were reviewed. We evaluated the incidence of TIVAP-related infection, patient characteristics, and bacteriologic data. Univariable analysis and multiple logistic regression analysis were used to evaluate the risk factors of TIVAP-related infection.
Results
A total of 3001 TIVAPs were implanted in 2897 patients, and the median follow-up time was 424 days (range: 1–2492 days), achieving a combined total of 1,648,731 catheter days. Thirty-one patients (1.0%) had early infection and 167 (5.6%) patients had late infection. In multivariate analysis, TIVAP combined with other surgeries (
p
= 0.03) and inpatient setting (
p
|
| doi_str_mv | 10.1007/s00423-021-02328-0 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2575367979</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2575367979</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-b0bac013da4ee5af5a4f51b860e4f0755e4f33abcd4d8d81bd0c97622414f11e3</originalsourceid><addsrcrecordid>eNp9kE9LAzEQxYMotla_gAfJ0cvqZJN026MU_xQKIug5ZLMT2bpNapIV-u2Nbu3RwzAD8-bx5kfIJYMbBlDdRgBR8gJKlouXswKOyJgJLotSSHZ8mAUfkbMY1wAwrebilIy4kBLEVIzJy9KZtkFnkGrX0NDGD2q1ST5Qm6t1Fk1qvaPe0uST7rodbTfbTruk6w7pFzrfR6qNwRjp1od0Tk6s7iJe7PuEvD3cvy6eitXz43JxtyoMF1Uqaqi1AcYbLRCltlILK1k9mwIKC5WUuXGua9OIZtbMWN2AmVfTshRMWMaQT8j14LsN_rPHmNSmjQa7HA1zJFXKSvL8bzXP0nKQmuBjDGjVNrQbHXaKgfpBqQaUKqNUvygV5KOrvX9fb7A5nPyxywI-CGJeuXcMau374PLP_9l-A01Kf4Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2575367979</pqid></control><display><type>article</type><title>Incidence and risk factor for infection of totally implantable venous access port</title><source>Springer Nature</source><creator>Chang, Tung-Cheng ; Yen, Min-Hsuan ; Kiu, Kee-Thai</creator><creatorcontrib>Chang, Tung-Cheng ; Yen, Min-Hsuan ; Kiu, Kee-Thai</creatorcontrib><description>Background
Totally implantable venous access ports (TIVAP) have been widely used in cancer patients for many years. The early infection (within 30 days after TIVAP implantation) rate of TIVAP accounts for about one-third of all TIVAP infections, and early infection often causes port removal and affects subsequent cancer treatment. This study investigated the incidence and risk factors for early and late infection after TIVAP implantation.
Methods
From January 2013 to December 2018, all adult cancer patients who received TIVAP implantation in Taipei Medical University Shuang-Ho Hospital were reviewed. We evaluated the incidence of TIVAP-related infection, patient characteristics, and bacteriologic data. Univariable analysis and multiple logistic regression analysis were used to evaluate the risk factors of TIVAP-related infection.
Results
A total of 3001 TIVAPs were implanted in 2897 patients, and the median follow-up time was 424 days (range: 1–2492 days), achieving a combined total of 1,648,731 catheter days. Thirty-one patients (1.0%) had early infection and 167 (5.6%) patients had late infection. In multivariate analysis, TIVAP combined with other surgeries (
p
= 0.03) and inpatient setting (
p
< 0.001) was the risk factor of early infection, and TIVAP combined with other surgeries (
p
= 0.007), hematological cancer (
p
= 0.03), and inpatient setting (
p
< 0.001) was the risk factor of late infection.
Conclusion
Inpatient TIVAP implantation and TIVAP implantation combined with other surgeries are associated with high rates of TIVAP-related early and late infections.</description><identifier>ISSN: 1435-2443</identifier><identifier>EISSN: 1435-2451</identifier><identifier>DOI: 10.1007/s00423-021-02328-0</identifier><identifier>PMID: 34550464</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Abdominal Surgery ; Adult ; Cardiac Surgery ; Catheter-Related Infections - epidemiology ; Catheterization, Central Venous - adverse effects ; Catheters, Indwelling - adverse effects ; General Surgery ; Humans ; Incidence ; Medicine ; Medicine & Public Health ; Original Article ; Risk Factors ; Thoracic Surgery ; Traumatic Surgery ; Vascular Surgery</subject><ispartof>Langenbeck's archives of surgery, 2022-02, Vol.407 (1), p.343-351</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c347t-b0bac013da4ee5af5a4f51b860e4f0755e4f33abcd4d8d81bd0c97622414f11e3</citedby><cites>FETCH-LOGICAL-c347t-b0bac013da4ee5af5a4f51b860e4f0755e4f33abcd4d8d81bd0c97622414f11e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34550464$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chang, Tung-Cheng</creatorcontrib><creatorcontrib>Yen, Min-Hsuan</creatorcontrib><creatorcontrib>Kiu, Kee-Thai</creatorcontrib><title>Incidence and risk factor for infection of totally implantable venous access port</title><title>Langenbeck's archives of surgery</title><addtitle>Langenbecks Arch Surg</addtitle><addtitle>Langenbecks Arch Surg</addtitle><description>Background
Totally implantable venous access ports (TIVAP) have been widely used in cancer patients for many years. The early infection (within 30 days after TIVAP implantation) rate of TIVAP accounts for about one-third of all TIVAP infections, and early infection often causes port removal and affects subsequent cancer treatment. This study investigated the incidence and risk factors for early and late infection after TIVAP implantation.
Methods
From January 2013 to December 2018, all adult cancer patients who received TIVAP implantation in Taipei Medical University Shuang-Ho Hospital were reviewed. We evaluated the incidence of TIVAP-related infection, patient characteristics, and bacteriologic data. Univariable analysis and multiple logistic regression analysis were used to evaluate the risk factors of TIVAP-related infection.
Results
A total of 3001 TIVAPs were implanted in 2897 patients, and the median follow-up time was 424 days (range: 1–2492 days), achieving a combined total of 1,648,731 catheter days. Thirty-one patients (1.0%) had early infection and 167 (5.6%) patients had late infection. In multivariate analysis, TIVAP combined with other surgeries (
p
= 0.03) and inpatient setting (
p
< 0.001) was the risk factor of early infection, and TIVAP combined with other surgeries (
p
= 0.007), hematological cancer (
p
= 0.03), and inpatient setting (
p
< 0.001) was the risk factor of late infection.
Conclusion
Inpatient TIVAP implantation and TIVAP implantation combined with other surgeries are associated with high rates of TIVAP-related early and late infections.</description><subject>Abdominal Surgery</subject><subject>Adult</subject><subject>Cardiac Surgery</subject><subject>Catheter-Related Infections - epidemiology</subject><subject>Catheterization, Central Venous - adverse effects</subject><subject>Catheters, Indwelling - adverse effects</subject><subject>General Surgery</subject><subject>Humans</subject><subject>Incidence</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Original Article</subject><subject>Risk Factors</subject><subject>Thoracic Surgery</subject><subject>Traumatic Surgery</subject><subject>Vascular Surgery</subject><issn>1435-2443</issn><issn>1435-2451</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kE9LAzEQxYMotla_gAfJ0cvqZJN026MU_xQKIug5ZLMT2bpNapIV-u2Nbu3RwzAD8-bx5kfIJYMbBlDdRgBR8gJKlouXswKOyJgJLotSSHZ8mAUfkbMY1wAwrebilIy4kBLEVIzJy9KZtkFnkGrX0NDGD2q1ST5Qm6t1Fk1qvaPe0uST7rodbTfbTruk6w7pFzrfR6qNwRjp1od0Tk6s7iJe7PuEvD3cvy6eitXz43JxtyoMF1Uqaqi1AcYbLRCltlILK1k9mwIKC5WUuXGua9OIZtbMWN2AmVfTshRMWMaQT8j14LsN_rPHmNSmjQa7HA1zJFXKSvL8bzXP0nKQmuBjDGjVNrQbHXaKgfpBqQaUKqNUvygV5KOrvX9fb7A5nPyxywI-CGJeuXcMau374PLP_9l-A01Kf4Q</recordid><startdate>20220201</startdate><enddate>20220201</enddate><creator>Chang, Tung-Cheng</creator><creator>Yen, Min-Hsuan</creator><creator>Kiu, Kee-Thai</creator><general>Springer Berlin Heidelberg</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220201</creationdate><title>Incidence and risk factor for infection of totally implantable venous access port</title><author>Chang, Tung-Cheng ; Yen, Min-Hsuan ; Kiu, Kee-Thai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-b0bac013da4ee5af5a4f51b860e4f0755e4f33abcd4d8d81bd0c97622414f11e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Abdominal Surgery</topic><topic>Adult</topic><topic>Cardiac Surgery</topic><topic>Catheter-Related Infections - epidemiology</topic><topic>Catheterization, Central Venous - adverse effects</topic><topic>Catheters, Indwelling - adverse effects</topic><topic>General Surgery</topic><topic>Humans</topic><topic>Incidence</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Original Article</topic><topic>Risk Factors</topic><topic>Thoracic Surgery</topic><topic>Traumatic Surgery</topic><topic>Vascular Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chang, Tung-Cheng</creatorcontrib><creatorcontrib>Yen, Min-Hsuan</creatorcontrib><creatorcontrib>Kiu, Kee-Thai</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Langenbeck's archives of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chang, Tung-Cheng</au><au>Yen, Min-Hsuan</au><au>Kiu, Kee-Thai</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence and risk factor for infection of totally implantable venous access port</atitle><jtitle>Langenbeck's archives of surgery</jtitle><stitle>Langenbecks Arch Surg</stitle><addtitle>Langenbecks Arch Surg</addtitle><date>2022-02-01</date><risdate>2022</risdate><volume>407</volume><issue>1</issue><spage>343</spage><epage>351</epage><pages>343-351</pages><issn>1435-2443</issn><eissn>1435-2451</eissn><abstract>Background
Totally implantable venous access ports (TIVAP) have been widely used in cancer patients for many years. The early infection (within 30 days after TIVAP implantation) rate of TIVAP accounts for about one-third of all TIVAP infections, and early infection often causes port removal and affects subsequent cancer treatment. This study investigated the incidence and risk factors for early and late infection after TIVAP implantation.
Methods
From January 2013 to December 2018, all adult cancer patients who received TIVAP implantation in Taipei Medical University Shuang-Ho Hospital were reviewed. We evaluated the incidence of TIVAP-related infection, patient characteristics, and bacteriologic data. Univariable analysis and multiple logistic regression analysis were used to evaluate the risk factors of TIVAP-related infection.
Results
A total of 3001 TIVAPs were implanted in 2897 patients, and the median follow-up time was 424 days (range: 1–2492 days), achieving a combined total of 1,648,731 catheter days. Thirty-one patients (1.0%) had early infection and 167 (5.6%) patients had late infection. In multivariate analysis, TIVAP combined with other surgeries (
p
= 0.03) and inpatient setting (
p
< 0.001) was the risk factor of early infection, and TIVAP combined with other surgeries (
p
= 0.007), hematological cancer (
p
= 0.03), and inpatient setting (
p
< 0.001) was the risk factor of late infection.
Conclusion
Inpatient TIVAP implantation and TIVAP implantation combined with other surgeries are associated with high rates of TIVAP-related early and late infections.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>34550464</pmid><doi>10.1007/s00423-021-02328-0</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1435-2443 |
| ispartof | Langenbeck's archives of surgery, 2022-02, Vol.407 (1), p.343-351 |
| issn | 1435-2443 1435-2451 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2575367979 |
| source | Springer Nature |
| subjects | Abdominal Surgery Adult Cardiac Surgery Catheter-Related Infections - epidemiology Catheterization, Central Venous - adverse effects Catheters, Indwelling - adverse effects General Surgery Humans Incidence Medicine Medicine & Public Health Original Article Risk Factors Thoracic Surgery Traumatic Surgery Vascular Surgery |
| title | Incidence and risk factor for infection of totally implantable venous access port |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T21%3A09%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence%20and%20risk%20factor%20for%20infection%20of%20totally%20implantable%20venous%20access%20port&rft.jtitle=Langenbeck's%20archives%20of%20surgery&rft.au=Chang,%20Tung-Cheng&rft.date=2022-02-01&rft.volume=407&rft.issue=1&rft.spage=343&rft.epage=351&rft.pages=343-351&rft.issn=1435-2443&rft.eissn=1435-2451&rft_id=info:doi/10.1007/s00423-021-02328-0&rft_dat=%3Cproquest_cross%3E2575367979%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c347t-b0bac013da4ee5af5a4f51b860e4f0755e4f33abcd4d8d81bd0c97622414f11e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2575367979&rft_id=info:pmid/34550464&rfr_iscdi=true |